Ultivent-M™ Cozycap

Indacaterol + Glycopyrronium + Mometasone Furoate
Beta-2 Agonist + Anticholinergic + Corticosteroid (Antiasthma)

Indication:

It is once-daily triple combination for the patients with moderate to severe asthma who treated earlier with an ICS/LABA dual combination.

Dosage & Administration:

1 Cozycap once daily by oral inhalation through revolizer^TM device.

Preparation:

Ultivent-M^TM Cozycap: Each box contains 10 Cozycaps in Alu-Alu blister.